By having a manufacturing facility in the USA or Europe, our foreign customers will be more comfortable when relying on us – in particular, bigger companies…
In Conversation
The shortage of medicines is a serious and growing issue. Here, it is very popular to blame the wholesalers. However, it is never the problem of…
Our advancement in biotechnology has been a key development for Gedeon Richter this year as we move forward in our transition to become a truly specialty…
Healthcare is a top priority for the UAE. Ensuring quality care for its population is a key deliverable the government is working towards
Access to innovation remains the most pressing matter: how to create a fast, effective, and sustainable reimbursement system
Sinovant Sciences is set up to take an integrated approach to develop a drug from Phase I all the way to approval.
What I am most proud of is how we have been able to build a relationship with the entire ecosystem, including patients, associations, healthcare providers, and…
We have two parallel objectives: improve patient access to medicines and foster economic growth in the region.
It is paramount that a sustainable internationalization strategy is devised and implemented if Vanessa Research is to help patients suffering from MVID
From the very beginning Helsinn took a very long-term, step-by-step approach when it came to entering the China market.
An important change that must happen in Hungary’s healthcare ecosystem is the implementation of patient registries and the collection and utilization of health data
The need for this technology is fueled by the unprecedented growth of new drugs registered each year in the oncology field
